Mission Bio recently won two awards in June 2016, including the CYTO Innovation Award at CYTO 2016 in Seattle, Washington, and the QB3@953 Amgen Golden Ticket Award. The CYTO Innovation Award recognizes the best presentation from the CYTO 2016 Technology Showcase, which highlights novel technologies for cell analysis that are in early stages of development to commercialization. The QB3@953 Amgen Golden Ticket Award supports the research and development efforts of startups with one year of lab space at the QB3@953 incubator, along with access to the scientific and business expertise from Amgen. Read more
Press
Mission Bio wins CYTO Innovation and QB3@953 Amgen Golden Ticket Awards
SHARE THIS PAGE
Press
Mission Bio and Human Cell Atlas Collaborate to Expand Access to Single-Cell Multiomics Ahead of HCA 2026 Meeting
Press
Mission Bio's Tapestri Enables Single-Cell Profiling of Residual Disease, Identifying AML Patients Likely to Benefit from Motixafortide in the Multicenter BLAST Trial
Press
Mission Bio's Tapestri Platform Powers Several Studies at EHA 2026, Redefining How the World's Leading Hematologists Resolve Clonal Architecture, MRD, and Treatment Response
Press